pillbase.ru

Afinitor

Active substance: everolimus

TABLET · EVEROLIMUS 5 mg/1

United StatesActive

Marketing holder: Novartis Pharmaceuticals Corporation

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 28
  • Алвида®
    таблетки, 10 мг (original in Russian, GRLS)
    ЛП-№(002749)-(РГ-RU)
    Акционерное общество "БИОКАД" (АО "БИОКАД")
  • Амеверол
    таблетки, 10 мг (original in Russian, GRLS)
    ЛП-№(013265)-(РГ-RU)
    ООО "АМЕДАРТ"
  • Амеверол
    таблетки, 10 мг (original in Russian, GRLS)
    ЛП-008130
    ООО "АМЕДАРТ"
  • Афинитор®
    таблетки, 2.5 мг (original in Russian, GRLS)
    ЛП-001690
    Новартис Фарма АГ
  • Афинитор®
    таблетки, 10 мг (original in Russian, GRLS)
    ЛП-№(004943)-(РГ-RU)
    Новартис Фарма АГ
All products in this country (28)
EU 2
  • Afinitor
    everolimus
    EMEA/H/C/001038
    Novartis Europharm Limited
  • Votubia
    everolimus
    EMEA/H/C/002311
    Novartis Europharm Limited
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-2e21-77c3-86ab-8310c3f7f66b,01a120c3-38fe-7e7e-88ef-47e775eff9c8,01a120c3-4cd4-7c11-b529-1b219b393c6d,01a120c3-4f5d-727f-85b4-669a46205274,01a120c3-54db-749a-bbcf-a17fb8015cfd;count=26 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-44d0-7e6c-9aed-05b6eb240d04,01a1208c-45c4-7a49-97f0-46e7236a4cd7,01a1208c-6599-7100-9ffb-76c35ab9b6c0,01a1208c-721e-73bb-bd89-7e15a8608237,01a1208c-8270-7d32-8813-791e265f90ed;count=98 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0078-0566
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 0078-0566 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0078-0566 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0078-0566 · Verified 2026-10-09 · open in source